Navigation Links
Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
Date:8/13/2013

LOUISVILLE, Ky., Aug. 13, 2013 /PRNewswire-iReach/ -- In collaboration with the James Graham Brown Cancer Center at the University of Louisville, LBIdx™ is advancing a breakthrough blood test, the Plasma Thermogram™ (pT). Based on a simple blood draw, researchers at LBIdx™ and the Brown Cancer Center see great promise for the pTtest as a "game-changer" allowing physicians to monitor cancer patients more closely. Monitoring is a critical part of cancer treatment and provides physicians with vital information in the fight against cancer.

LBIdx™ and the Brown Cancer Center are initiating a clinical study that will demonstrate the pT test's capabilities for improved monitoring of melanoma patients at dangerous risk of metastasis and for response to medical treatment. Director Donald Miller M.D., Ph.D. and Deputy Director Jason A. Chesney, M.D., Ph.D., will be co-investigators of the planned study to detect earlier signs of change in disease status. Researchers expect the pTwill provide a unique insight into cancer status leading to improved medical response options, including therapy. Equally important, this test stands to be an earlier indicator or remission or relapse.  In all, the test stands to help answer those age-old questions, "Am I winning my battle with cancer?" and "Is my cancer gone?" 

Current medical practice frequently relies on medical imaging procedures, like CT scans, to monitor melanoma patients. But due to the high dose radiation exposure from each procedure, their use by physicians is limited, which can hinder patient monitoring.  In addition, the FDA is striving to reduce unnecessary radiation exposure from these medical imaging procedures which are the greatest contributors to total radiation exposure within the U.S.

Alfred "Ben" Jenson, Professor of Vaccinology at the James Graham Brown Cancer Center and co-inventor of the pThas been a strong supporter of the pT's cancer monitoring potential.  Ben is also known for his work as co-inventor of the cervical cancer vaccine, Gardasil, and sees potential for the pT as a monitoring tool for a multitude of cancers, including difficult-to-detect oral cancers.

LBIdx™ is a start-up company, focused on the commercialization of pT tests for cancer monitoring and prognosis. It is currently raising funds via a crowd funding campaign allowing the public, who will benefit from such a test, to support this enhanced cancer monitoring effort. Crowd funding is a relatively new concept approved by the U.S. Jobs Act of 2012. Details of their 'Breakthrough in Cancer Detection & Monitoring' campaign can be found on the Indiegogo crowd funding website using the following link, http://igg.me/at/CancerDetectionStudy.

About Louisville Bioscience, Inc.

LBIdx™, headquartered in Louisville, Kentucky, is a start-up company with an exclusive license to the University of Louisville Plasma Thermogram™ (pT) technology and focused on the commercialization of pT tests for cancer monitoring and prognosis.  The novel pT blood test can provide earlier detection of disease, effectively assess status of cancer remission and improve monitoring in response to therapy for numerous cancers including: melanoma, breast, cervical, ovarian and lung cancers. The pT diagnostic platform utilizes Differential Scanning Calorimetry (DSC) to generate a robust temperature-induced melting profile of the major blood proteins. The LBIdx™ core technology was invented by the University of Louisville team of Dr. Jonathan Chaires (James Graham Brown Endowed Chair of Cancer Biophysics), Dr. Nichola Garbett and Dr. Alfred "Ben" Jenson. For more information, please visit www.lbidx.com

Media Contact: Michael Birdsell, LBIdx, 502.414.1243, mbirdsell@lbidx.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE LBIdx
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Cloud-Based Investigator Portal from Veeva Systems Speeds Clinical Study Start-Up
2. Structure-Based Drug Design Conference in Boston, Starting June 19 PLUS These 62 Start-ups and Small Companies Will Transform Drug Delivery Technology
3. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
4. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
5. Helping Start-Ups Avoid Slow-Downs
6. Fuisz Pharma Announces Intent to Divest Strategic Patent for Detection of Opioid Abuse; Seeks Offers for Patent through May 2013
7. $1,000,000 Global B.R.A.I.N. Prize Seeks Applicants
8. American Academy of Pain Medicine Reacts to PROP Petition to the FDA that Seeks to Limit Pain Medications for Legitimate Noncancer Pain Sufferers
9. Searcy Denney Scarola Barnhart & Shipley PA Seeks Damages Caused by Recalled Product
10. Separation Design Group Launches Crowd-Funding Campaign for Worlds Smallest Oxygen Machine
11. Prosum Kicks Off Crowd Funding for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Feb. 23, 2017  The particle counters market ... 2021 from USD 275.9 million in 2016, at ... full report: http://www.reportlinker.com/p04718602-summary/view-report.html The ... pharmaceutical R&D, and growth in manufacturing industries in ... growth for particle counters. On the other hand, ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)... Nevro Corp. (NYSE: NVRO), a global medical device company that ... pain, today reported financial results for the three months and ... Accomplishment & Highlights: Achieved revenue of $228.5 ... as reported, over the prior year U.S. revenue ... the prior year International revenue of $55.2 ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 23, 2017 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Miami Beach to host its Swirl: Miami Wine Tasting Event on March 28, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., ... From Not to Hot,” which will begin airing on February 24, 2017. The show ... from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series ...
(Date:2/23/2017)... Mass. (PRWEB) , ... February 23, 2017 , ... ... as an approved content provider for the National Institute for Health and ... and social care-related organizations in the National Health Service (NHS) to search, order ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... exciting, new, interactive publication where generations converge and explore the world from different ... worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and find greater ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... and community for those in the fight against cancer, has produced a seminal ... success. HRA will release top-line findings in a webinar, Defining Compassionate Care ...
Breaking Medicine News(10 mins):